Publication & Citation Trends
Most Cited Works
Publications
100 total
Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project PDF
Cited by 497
OpenAlex
A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line Metastatic NSCLC Treatment: Results from the MYSTIC Study PDF
Cited by 110
OpenAlex
Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non–Small Cell Lung Cancer PDF
Cited by 103
OpenAlex
<i>BRCA</i> Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma
Cited by 418
OpenAlex
Cell-Free DNA Next-Generation Sequencing Prediction of Response and Resistance to Third-Generation EGFR Inhibitor
Cited by 63
OpenAlex
Abstract 5603: Analytical validation of a comprehensive 500-gene ctDNA panel designed for immuno-oncology and DNA damage research
Cited by 24
OpenAlex
Development and analytical validation of a plasma-based tumor mutational burden (TMB) score from next-generation sequencing panels PDF
Cited by 18
OpenAlex
Abstract 4272: A novel approach to differentiation of somatic vs. germline variants in liquid biopsies using a betabinomial model
Cited by 13
OpenAlex
Research Topics
Cancer Genomics and Diagnostics
(76)
Lung Cancer Treatments and Mutations
(35)
Cancer Immunotherapy and Biomarkers
(16)
PARP inhibition in cancer therapy
(11)
Molecular Biology Techniques and Applications
(11)
Frequent Co-Authors
Affiliations
Broad Institute
Brown University
University of California, San Diego
Harvard–MIT Division of Health Sciences and Technology
Centro Científico Tecnológico - San Juan